{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T18:12:35Z","timestamp":1776103955907,"version":"3.50.1"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011929","name":"Programa Operacional Tem\u00e1tico Factores de Competitividade","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["2022.15560"],"award-info":[{"award-number":["2022.15560"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["LA\/P\/0058\/2020"],"award-info":[{"award-number":["LA\/P\/0058\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["UIDP\/04539\/2020"],"award-info":[{"award-number":["UIDP\/04539\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["UIDB\/04539\/2020"],"award-info":[{"award-number":["UIDB\/04539\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Drug Delivery Science and Technology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jddst.2026.108195","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:48:08Z","timestamp":1772264888000},"page":"108195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hydrogels as delivery platforms for advancing T cell therapies"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8415-3510","authenticated-orcid":false,"given":"Diana","family":"Correia","sequence":"first","affiliation":[]},{"given":"Henrique","family":"Faneca","sequence":"additional","affiliation":[]},{"given":"Huiliang","family":"Wang","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7785-5275","authenticated-orcid":false,"given":"Rosemeyre","family":"Cordeiro","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.jddst.2026.108195_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric antigen receptor therapy","volume":"379","author":"J","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jddst.2026.108195_bib2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4062\/biomolther.2023.197","article-title":"Engineered T cell receptor for cancer immunotherapy","volume":"32","author":"Lee","year":"2024","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.jddst.2026.108195_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s40364-024-00625-6","article-title":"Cancer immunotherapy and its facilitation by nanomedicine","volume":"12","author":"Sui","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.jddst.2026.108195_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25084170","article-title":"Car T cells in solid tumors: overcoming obstacles","volume":"25","author":"Rojas-Quintero","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jddst.2026.108195_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1389201019666180418095526","article-title":"CAR T-cell therapy: a new era in cancer immunotherapy","volume":"19","author":"Miliotou","year":"2018","journal-title":"Curr. Pharm. Biotechnol"},{"key":"10.1016\/j.jddst.2026.108195_bib6","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41419-018-0918-x","article-title":"The biological basis and clinical symptoms of CAR-T therapy-associated toxicites","volume":"9","author":"Titov","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jddst.2026.108195_bib7","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s12094-023-03368-2","article-title":"CAR-T cell therapy: a game-changer in cancer treatment and beyond","volume":"26","author":"Utkarsh","year":"2024","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.jddst.2026.108195_bib8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jconrel.2019.12.047","article-title":"Current challenges and emerging opportunities of CAR-T cell therapies","volume":"319","author":"Abreu","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.jddst.2026.108195_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2022.11.038","article-title":"Polymer- and lipid-based gene delivery technology for CAR T cell therapy","volume":"353","author":"Pinto","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.jddst.2026.108195_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106454","article-title":"Nanotechnology-based chimeric antigen receptor T-cell therapy in treating solid tumor","volume":"184","author":"Zuo","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jddst.2026.108195_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/ejh.14074","article-title":"Chimeric antigen receptor T-cell therapy in hematologic malignancies: successes, challenges, and opportunities","volume":"112","author":"Ho","year":"2024","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.jddst.2026.108195_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40164-023-00435-w","article-title":"Current approaches to develop \u201coff-the-shelf\u201d chimeric antigen receptor (CAR)-T cells for cancer treatment: a systematic review","volume":"12","author":"Aparicio","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.jddst.2026.108195_bib13","first-page":"166","article-title":"FDA approves fourth CAR-T cell therapy","volume":"20","author":"Mullard","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jddst.2026.108195_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111093","article-title":"Strategies for modifying the chimeric antigen receptor (CAR) to improve safety and reduce toxicity in CAR T cell therapy for cancer","volume":"125","author":"Sayadmanesh","year":"2023","journal-title":"Int. Immunopharmacol"},{"key":"10.1016\/j.jddst.2026.108195_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068956","article-title":"Chimeric antigen receptor T cell therapy for cancer: clinical applications and practical considerations","volume":"378","author":"Maakaron","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.jddst.2026.108195_bib16","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2406526","article-title":"Obecabtagene autoleucel in adults with B-cell acute lymphoblastic leukemia","volume":"391","author":"Roddie","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jddst.2026.108195_bib17","first-page":"469","article-title":"FDA-Approved chimeric antigen receptor (CAR)-T cell therapy for different Cancers-A recent perspective, mol","volume":"67","author":"Thirumalaisamy","year":"2025","journal-title":"Biotechnol."},{"key":"10.1016\/j.jddst.2026.108195_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115688","article-title":"CAR-T cell therapy: from the shop to cancer therapy","volume":"24","author":"Uscanga-Palomeque","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jddst.2026.108195_bib19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/02648725.2018.1430465","article-title":"CAR T-cells for cancer therapy","volume":"33","author":"Muhammad","year":"2017","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"10.1016\/j.jddst.2026.108195_bib20","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.3390\/cancers16162858","article-title":"Strategies for improving CAR T cell persistence in solid tumors","volume":"16","author":"Wittling","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jddst.2026.108195_bib21","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.3390\/cancers15133476","article-title":"Fine-tuning through generations: advances in structure and production of CAR-T therapy","volume":"15","author":"Zheng","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jddst.2026.108195_bib22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41551-018-0235-9","article-title":"Programming CAR-T cells to kill cancer","volume":"2","author":"Labanieh","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jddst.2026.108195_bib23","article-title":"CAR-T cell therapy in hematological malignancies: current opportunities and challenges","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jddst.2026.108195_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000496870","article-title":"Chimeric antigen receptor T cells: a race to revolutionize cancer therapy","volume":"46","author":"Subklewe","year":"2019","journal-title":"Transfus. Med. Hemotherapy"},{"key":"10.1016\/j.jddst.2026.108195_bib25","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.3390\/ijms24065688","article-title":"CAR T-cell persistence correlates with improved outcome in patients with B-cell lymphoma","volume":"24","author":"Wittibschlager","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jddst.2026.108195_bib26","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3390\/cancers16081599","article-title":"Chimeric antigen receptor (CAR) T-cell therapy in hematologic malignancies: clinical implications and limitations","volume":"16","author":"Bl\u00fcm","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jddst.2026.108195_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ccell.2020.07.005","article-title":"Engineering CAR-T cells for next-generation cancer therapy","volume":"38","author":"Hong","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jddst.2026.108195_bib28","article-title":"Advances in universal CAR-T cell therapy, front","volume":"12","author":"Lin","year":"2021","journal-title":"Immunol. Ser."},{"key":"10.1016\/j.jddst.2026.108195_bib29","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2114254","article-title":"Current updates on generations, approvals, and clinical trials of CAR T-cell therapy","volume":"18","author":"Asmamaw Dejenie","year":"2022","journal-title":"Hum. Vaccin. Immunother"},{"key":"10.1016\/j.jddst.2026.108195_bib30","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1177\/1078155219836480","article-title":"Paiboon Jungsuwadee, chimeric antigen receptor T-cell therapy: foundational science and clinical knowledge for pharmacy practice","volume":"25","author":"Dushenkov","year":"2019","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.jddst.2026.108195_bib31","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.15419\/bmrat.v9i2.726","article-title":"CAR-T-cell therapy: present progress and future strategies","volume":"9","author":"Abbasi","year":"2022","journal-title":"Biomed. Res. Ther."},{"key":"10.1016\/j.jddst.2026.108195_bib32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-023-05707-3","article-title":"CAR immune cells: design principles, resistance and the next generation","volume":"614","author":"Labanieh","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jddst.2026.108195_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1546172","article-title":"Tandem CAR-T cell therapy: recent advances and current challenges","volume":"16","author":"G\u00f3mez-Melero","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jddst.2026.108195_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.109225","article-title":"Injectable hydrogel-based drug delivery systems for enhancing the efficacy of radiation therapy: a review of recent advances","volume":"35","author":"Xu","year":"2024","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jddst.2026.108195_bib35","article-title":"The role of chimeric antigen receptor-T cell therapy in the treatment of hematological malignancies: advantages, trials, and tribulations, and the road ahead","volume":"13","author":"Reddy","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jddst.2026.108195_bib36","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.apsb.2018.03.001","article-title":"The application of CAR-T cell therapy in hematological malignancies: advantages and challenges","volume":"8","author":"Zhao","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jddst.2026.108195_bib37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12032-023-02146-y","article-title":"Revolutionizing cancer treatment: a comprehensive review of CAR-T cell therapy","volume":"40","author":"Dabas","year":"2023","journal-title":"Med. Oncol."},{"key":"10.1016\/j.jddst.2026.108195_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac5415","article-title":"Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia","volume":"7","author":"Porter","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jddst.2026.108195_bib39","article-title":"Hydrogel-based strategies to enhance T-Cell performance for solid tumor immunotherapy","volume":"7","author":"Oh","year":"2024","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jddst.2026.108195_bib40","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1039\/D3NR05768B","article-title":"Recent advances in biomaterial designs for assisting CAR-T cell therapy towards potential solid tumor treatment","volume":"16","author":"Lin","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.jddst.2026.108195_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115083","article-title":"Hydrogel drug delivery systems for minimally invasive local immunotherapy of cancer","volume":"202","author":"Mikhail","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jddst.2026.108195_bib42","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.3390\/app14072926","article-title":"State-of-all-the-art and prospective hydrogel-based transdermal drug delivery systems","volume":"14","author":"Alex","year":"2024","journal-title":"Appl. Sci."},{"key":"10.1016\/j.jddst.2026.108195_bib43","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.eurpolymj.2014.11.024","article-title":"Biomedical applications of hydrogels: a review of patents and commercial products,","volume":"65","author":"Cal\u00f3","year":"2015","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.jddst.2026.108195_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202511779","article-title":"Genetically engineered bacteria-derived hydrogel orchestrates T cell spatial dynamics for triple-negative breast cancer immunotherapy","volume":"35","author":"Jia","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jddst.2026.108195_bib45","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41570-022-00420-7","article-title":"Chemical strategies to engineer hydrogels for cell culture","volume":"6","author":"Lou","year":"2022","journal-title":"Nat. Rev. Chem"},{"key":"10.1016\/j.jddst.2026.108195_bib46","doi-asserted-by":"crossref","first-page":"515","DOI":"10.15171\/apb.2017.064","article-title":"Cross-linked hydrogel for pharmaceutical applications: a review","volume":"7","author":"Parhi","year":"2017","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.jddst.2026.108195_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2024.103095","article-title":"Innovations in hydrogel-based manufacturing: a comprehensive review of direct ink writing technique for biomedical applications","volume":"324","author":"Baniasadi","year":"2024","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.jddst.2026.108195_bib48","article-title":"Emerging trends in the application of hydrogel-based biomaterials for enhanced wound healing: a literature review","volume":"261","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jddst.2026.108195_bib49","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3390\/gels10070476","article-title":"Hydrogel-based therapies for ischemic and hemorrhagic stroke: a comprehensive review","volume":"10","author":"Rotaru-Z\u0103v\u0103leanu","year":"2024","journal-title":"Gels"},{"key":"10.1016\/j.jddst.2026.108195_bib50","series-title":"Polymer Physics","author":"Rubinstein","year":"2003"},{"key":"10.1016\/j.jddst.2026.108195_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120313","article-title":"CCL21-loaded 3D hydrogels for T cell expansion and differentiation","volume":"259","author":"P\u00e9rez del R\u00edo","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.jddst.2026.108195_bib52","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/gels10040262","article-title":"Advances in hydrogel-based drug delivery systems","volume":"10","author":"Liu","year":"2024","journal-title":"Gels"},{"key":"10.1016\/j.jddst.2026.108195_bib53","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1208\/s12249-024-02786-x","article-title":"A comprehensive review of hydrogel-based drug delivery systems: classification, properties, recent trends, and applications","volume":"25","author":"Hameed","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jddst.2026.108195_bib54","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1021\/acs.biomac.6b01604","article-title":"Hydrogels for therapeutic delivery: current developments and future directions","volume":"18","author":"Buwalda","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jddst.2026.108195_bib55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.actbio.2022.09.068","article-title":"Design of hydrogel-based scaffolds for in vitro three-dimensional human skin model reconstruction","volume":"153","author":"Tan","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jddst.2026.108195_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.71","article-title":"Designing hydrogels for controlled drug delivery","volume":"1","author":"Li","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jddst.2026.108195_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2024.112906","article-title":"Unlocking the biological response of smart stimuli-responsive hydrogels and their application in biological systems","volume":"209","author":"Kumi","year":"2024","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.jddst.2026.108195_bib58","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3390\/gels10110717","article-title":"Hydrogel for sustained delivery of therapeutic agents","volume":"10","author":"Musuc","year":"2024","journal-title":"Gels"},{"key":"10.1016\/j.jddst.2026.108195_bib59","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1039\/D0SM00207K","article-title":"Controlled release of entrapped nanoparticles from thermoresponsive hydrogels with tunable network characteristics","volume":"16","author":"Wang","year":"2020","journal-title":"Soft Matter"},{"key":"10.1016\/j.jddst.2026.108195_bib60","article-title":"Biomedical applications of stimuli-responsive \u201csmart\u201d interpenetrating polymer network hydrogels","volume":"25","author":"Wu","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jddst.2026.108195_bib61","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/gels10070440","article-title":"Stimulus-responsive hydrogels for targeted cancer therapy","volume":"10","author":"Solanki","year":"2024","journal-title":"Gels"},{"key":"10.1016\/j.jddst.2026.108195_bib62","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s13770-021-00369-6","article-title":"Short review on advances in hydrogel-based drug delivery strategies for cancer immunotherapy","volume":"19","author":"Seo","year":"2022","journal-title":"Tissue Eng. Regen. Med"},{"key":"10.1016\/j.jddst.2026.108195_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2022.107747","article-title":"Application of nanotechnology in CAR-T-cell immunotherapy","volume":"34","author":"Zeng","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jddst.2026.108195_bib64","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.actbio.2023.10.002","article-title":"Injectable hydrogels for personalized cancer immunotherapies","volume":"172","author":"Mohaghegh","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jddst.2026.108195_bib65","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-024-01852-x","article-title":"Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions","volume":"9","author":"Lu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jddst.2026.108195_bib68","doi-asserted-by":"crossref","first-page":"47355","DOI":"10.1021\/acsami.0c16478","article-title":"A hydrogel-integrated culture device to interrogate T cell activation with physicochemical cues,","volume":"12","author":"Chin","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jddst.2026.108195_bib69","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.fmre.2023.05.016","article-title":"A tetramethylpyrazine releasing hydrogel can potentiate CAR-T cell therapy against triple negative breast cancer by reprogramming tumor vasculatures,","volume":"5","author":"Liu","year":"2025","journal-title":"Fundam. Res."},{"key":"10.1016\/j.jddst.2026.108195_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309667","article-title":"Promoting the recruitment, engagement, and reinvigoration of effector T cells via an injectable hydrogel with a supramolecular binding capability for cancer immunotherapy","volume":"35","author":"Zhu","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jddst.2026.108195_bib71","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.7150\/thno.30577","article-title":"Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy","volume":"9","author":"Song","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jddst.2026.108195_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202100814","article-title":"Localized chemotherapy based on injectable hydrogel boosts the antitumor activity of adoptively transferred T lymphocytes in vivo","volume":"10","author":"Cao","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jddst.2026.108195_bib73","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.2147\/IJN.S249174","article-title":"Superior antitumor efficacy of IFN-\u03b12b-Incorporated photo-cross-linked hydrogels combined with T cell transfer and low-dose irradiation against gastric cancer","volume":"15","author":"Liu","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.jddst.2026.108195_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201601776","article-title":"A powerful CD8+ T-Cell stimulating D-Tetra-Peptide hydrogel as a very promising vaccine adjuvant","volume":"29","author":"Luo","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jddst.2026.108195_bib75","article-title":"Injectable supramolecular hydrogels for in situ programming of Car-T cells toward solid tumor immunotherapy","volume":"36","author":"Zhu","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jddst.2026.108195_bib76","article-title":"Chemokine-based injectable navigation system for enhancing CAR-T cell therapy against solid tumors","volume":"34","author":"Wan","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jddst.2026.108195_bib77","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1021\/acsnano.2c10845","article-title":"Extracellular Matrix Viscosity Reprogramming by In Situ Au Bioreactor-Boosted Microwavegenetics Disables Tumor Escape in CAR-T Immunotherapy","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jddst.2026.108195_bib66","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3390\/pharmaceutics12121188","article-title":"Hydrogels as drug delivery systems: a review of current characterization and evaluation techniques","volume":"12","author":"Vigata","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jddst.2026.108195_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2020.109621","article-title":"Polymer scaffolds as drug delivery systems","volume":"129","author":"Calori","year":"2020","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.jddst.2026.108195_bib78","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1016\/j.biomaterials.2008.05.033","article-title":"Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy","volume":"29","author":"Hori","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.jddst.2026.108195_bib79","doi-asserted-by":"crossref","first-page":"56712","DOI":"10.1021\/acsami.0c15239","article-title":"Injectable porous microchips with oxygen reservoirs and an immune-niche enhance the efficacy of CAR T cell therapy in solid tumors","volume":"12","author":"Luo","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jddst.2026.108195_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122052","article-title":"Metformin-containing hydrogel scaffold to augment CAR-T therapy against post-surgical solid tumors","volume":"295","author":"Chao","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jddst.2026.108195_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121972","article-title":"T cell-responsive macroporous hydrogels for in situ T cell expansion and enhanced antitumor efficacy","volume":"293","author":"Bhatta","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jddst.2026.108195_bib82","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jocn.2018.06.005","article-title":"Hyaluronic acid based low viscosity hydrogel as a novel carrier for convection enhanced delivery of CAR T cells","volume":"56","author":"Atik","year":"2018","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jddst.2026.108195_bib83","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41551-021-00712-1","article-title":"Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets","volume":"5","author":"Hu","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jddst.2026.108195_bib84","article-title":"Ex vivo expansion and hydrogel-mediated in vivo delivery of tissue-resident memory T cells for immunotherapy","volume":"10","author":"Li","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jddst.2026.108195_bib85","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1021\/bm500502n","article-title":"Thermoreversible poly(ethylene glycol)-g-Chitosan hydrogel as a therapeutic T lymphocyte depot for localized glioblastoma immunotherapy","volume":"15","author":"Tsao","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jddst.2026.108195_bib86","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s43018-020-00119-y","article-title":"GD2-specific CAR T cells encapsulated in an injectable hydrogel control retinoblastoma and preserve vision","volume":"1","author":"Wang","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.jddst.2026.108195_bib87","article-title":"Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastoma","volume":"7","author":"Ogunnaike","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jddst.2026.108195_bib88","article-title":"Delivery of CAR-T cells in a transient injectable stimulatory hydrogel niche improves treatment of solid tumors","volume":"8","author":"Grosskopf","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jddst.2026.108195_bib89","article-title":"Basement membrane hydrogels dampen CAR-T cell activation: nanofibrillar cellulose gels as alternative to preserve T cell function in 3D cell cultures","author":"Revilla","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.jddst.2026.108195_bib90","doi-asserted-by":"crossref","first-page":"37514","DOI":"10.1021\/acsami.2c10727","article-title":"Customized multifunctional peptide hydrogel scaffolds for CAR-T-Cell rapid proliferation and solid tumor immunotherapy","volume":"14","author":"Jie","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jddst.2026.108195_bib91","article-title":"Supramolecular peptide hydrogel epitope vaccine functionalized with CAR-T cells for the treatment of solid tumors","volume":"31","author":"Yang","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jddst.2026.108195_bib92","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1021\/acs.nanolett.8b01406","article-title":"Engineering dendritic-cell-based vaccines and PD-1 blockade in self-assembled peptide nanofibrous hydrogel to amplify antitumor T-Cell immunity","volume":"18","author":"Yang","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.jddst.2026.108195_bib93","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1021\/acsbiomaterials.3c01617","article-title":"Nanofibrous MultiDomain peptide hydrogels provide T cells a 3D, cytocompatible environment for cell expansion and antigen-specific killing","volume":"10","author":"Leyva-Aranda","year":"2024","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.jddst.2026.108195_bib94","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1039\/D2BM00486K","article-title":"Enhanced human T cell expansion with inverse opal hydrogels","volume":"10","author":"Santos","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jddst.2026.108195_bib95","doi-asserted-by":"crossref","first-page":"16548","DOI":"10.1021\/acsami.4c19942","article-title":"Lymph-node inspired hydrogels enhance CAR expression and proliferation of CAR T cells","volume":"17","author":"Castellote-Borrell","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jddst.2026.108195_bib96","doi-asserted-by":"crossref","first-page":"50139","DOI":"10.1021\/acsami.4c06183","article-title":"3D printing as a strategy to scale-up biohybrid hydrogels for T cell manufacture","volume":"16","author":"P\u00e9rez Del R\u00edo","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jddst.2026.108195_bib97","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1021\/acsmacrolett.3c00271","article-title":"Mechanical properties affect primary T cell activation in 3D bioprinted hydrogels","volume":"12","author":"Joseph","year":"2023","journal-title":"ACS Macro Lett."},{"key":"10.1016\/j.jddst.2026.108195_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121872","article-title":"Injectable and photocurable CAR-T cell formulation enhances the anti-tumor activity to melanoma in mice","volume":"291","author":"Zhou","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jddst.2026.108195_bib99","article-title":"Improved efficacy of triple-negative breast cancer immunotherapy via hydrogel-based co-delivery of CAR-T cells and mitophagy agonist","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jddst.2026.108195_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101477","article-title":"Micro-hydrogel injectables that deliver effective CAR-T immunotherapy against 3D solid tumor spheroids","volume":"24","author":"Suraiya","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.jddst.2026.108195_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02798","article-title":"Injectable biomimetic hydrogels as tools for efficient T cell expansion and delivery","volume":"9","author":"Weiden","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jddst.2026.108195_bib102","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1039\/D2TB00274D","article-title":"Injectable Diels\u2013Alder cycloaddition hydrogels with tuneable gelation, stiffness and degradation for the sustained release of T-lymphocytes","volume":"10","author":"Yan","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jddst.2026.108195_bib103","doi-asserted-by":"crossref","first-page":"13734","DOI":"10.1039\/D4RA01968G","article-title":"In vitro encapsulation and expansion of T and CAR-T cells using 3D synthetic thermo-responsive matrices","volume":"14","author":"Lizana-Vasquez","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.jddst.2026.108195_bib104","doi-asserted-by":"crossref","DOI":"10.1002\/jbm.a.37823","article-title":"In vitro assessment of thermo-responsive scaffold as a 3D synthetic matrix for CAR-T potency testing against glioblastoma spheroids","volume":"113","author":"Lizana-Vasquez","year":"2025","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jddst.2026.108195_bib105","article-title":"CAR-T cells locally delivered in porcine decellularized matrix hydrogels enhance survival in post-resection glioblastoma","author":"Logun","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.jddst.2026.108195_bib106","article-title":"Convection-enhanced delivery of therapeutics for brain disease, and its optimization","volume":"20","author":"Raghavan","year":"2006","journal-title":"Neurosurgical Focus FOC"},{"key":"10.1016\/j.jddst.2026.108195_bib107","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s13346-023-01405-9","article-title":"Drug delivery methods for cancer immunotherapy","volume":"14","author":"P\u00e9rez-Herrero","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jddst.2026.108195_bib108","article-title":"Delivering CAR-T cells into solid tumors via hydrogels","volume":"2","author":"Wu","year":"2023","journal-title":"MedComm \u2013 Oncol."},{"key":"10.1016\/j.jddst.2026.108195_bib109","article-title":"Heat-inducible CAR-T overcomes adverse mechanical tumor microenvironment in a 3D bioprinted glioblastoma model","volume":"26","author":"Tang","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jddst.2026.108195_bib110","article-title":"Bioprinting of tumor immune microenvironment for immunotherapy","volume":"10","author":"Kim","year":"2024","journal-title":"IJB"},{"key":"10.1016\/j.jddst.2026.108195_bib111","article-title":"Evaluating CAR-T cell therapy in a hypoxic 3D tumor model","volume":"8","author":"Ando","year":"2019","journal-title":"Adv. Healthc. Mater."}],"container-title":["Journal of Drug Delivery Science and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1773224726002200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1773224726002200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:04:17Z","timestamp":1776099857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1773224726002200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":111,"alternative-id":["S1773224726002200"],"URL":"https:\/\/doi.org\/10.1016\/j.jddst.2026.108195","relation":{},"ISSN":["1773-2247"],"issn-type":[{"value":"1773-2247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrogels as delivery platforms for advancing T cell therapies","name":"articletitle","label":"Article Title"},{"value":"Journal of Drug Delivery Science and Technology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jddst.2026.108195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108195"}}